Nishihira Kensaku, Kuriyama Nehiro, Kadooka Kosuke, Honda Yasuhiro, Yamamoto Keisuke, Nishino Shun, Ebihara Suguru, Ogata Kenji, Kimura Toshiyuki, Koiwaya Hiroshi, Shibata Yoshisato
Department of Cardiology, Miyazaki Medical Association Hospital Miyazaki Japan.
Circ Rep. 2022 Sep 1;4(10):474-481. doi: 10.1253/circrep.CR-22-0048. eCollection 2022 Oct 7.
As life expectancy rises, percutaneous coronary intervention (PCI) is being performed more frequently, even in elderly patients with acute myocardial infarction (AMI). This study evaluated outcomes of elderly patients with AMI complicated by heart failure (AMIHF), as defined by Killip Class ≥2 at admission, who undergo PCI. We retrospectively analyzed 185 patients with AMIHF aged ≥80 years (median age 85 years) who underwent PCI between 2009 and 2019. The median follow-up period was 572 days. The rates of in-hospital major bleeding (Bleeding Academic Research Consortium Type 3 or 5) and in-hospital all-cause mortality were 20.5% and 25.9%, respectively. The proportion of frail patients increased during hospitalization, from 40.6% at admission to 59.2% at discharge (P<0.01). The cumulative incidence of all-cause mortality was 36.3% at 1 year and 44.1% at 2 years. After adjusting for confounders, advanced age, Killip Class 4, final Thrombolysis in Myocardial Infarction flow grade <3, and longer door-to-balloon time were associated with higher mortality, whereas higher left ventricular ejection fraction and cardiac rehabilitation were associated with lower mortality (all P<0.05). Progression of frailty during hospitalization was an independent risk factor for long-term mortality in hospital survivors (P<0.01). The management of patients with AMIHF aged ≥80 years who undergo PCI remains challenging, with high rates of in-hospital major bleeding, frailty progression, and mortality.
随着预期寿命的延长,经皮冠状动脉介入治疗(PCI)的实施频率越来越高,即使是在患有急性心肌梗死(AMI)的老年患者中。本研究评估了入院时Killip分级≥2级的合并心力衰竭(AMIHF)的老年AMI患者接受PCI后的结局。我们回顾性分析了2009年至2019年间接受PCI的185例年龄≥80岁(中位年龄85岁)的AMIHF患者。中位随访期为572天。住院期间严重出血(出血学术研究联盟3型或5型)率和住院期间全因死亡率分别为20.5%和25.9%。虚弱患者的比例在住院期间增加,从入院时的40.6%增至出院时的59.2%(P<0.01)。1年时全因死亡率的累积发生率为36.3%,2年时为44.1%。在对混杂因素进行校正后,高龄、Killip 4级、心肌梗死溶栓治疗最终血流分级<3以及门球时间延长与较高死亡率相关,而较高的左心室射血分数和心脏康复与较低死亡率相关(均P<0.05)。住院期间虚弱程度的进展是住院幸存者长期死亡的独立危险因素(P<0.01)。对于年龄≥80岁的接受PCI的AMIHF患者的管理仍然具有挑战性,住院期间严重出血、虚弱进展和死亡率均较高。